Justin Zamirowski

Justin Zamirowski has extensive work experience in the pharmaceutical and biotech industries. Justin began their career at Abbott as a Rare Reagent GMP Manufacturing Specialist, where they conducted GMP manufacturing of antibodies and antigens for diagnostic immunoassays. Justin later joined Pfizer (Wyeth) as a Psychiatric Specialty Manager and Territory Rep, ranking in the top 10% of sales and managing a team of direct reports.

Justin then worked at ESP Pharma as a Sales Supervisor and Hospital Representative, successfully relaunching products in major institutions and achieving sales growth. At PDL BioPharma, they held the roles of Sr. Account Executive, Market Access, and Sr. Manager, Business Development, coordinating asset sales and developing market access strategies.

Justin joined Otsuka Pharmaceutical Companies (U.S.) as Sr. Director, Program Management and Commercial Operations, where they led cross-functional launch teams and developed launch excellence competency. Justin also served as Director, Project Management, running the project management function and establishing a subsidiary in Canada.

Justin then became VP Market Development and Operational Excellence at Edge Therapeutics, Inc., developing all aspects of the commercial strategy for a late-stage orphan hospital product and gaining Board approval plans for launch readiness.

Justin's most recent role was at Better Therapeutics, where they served as Chief Commercial Officer, responsible for commercial strategy and operations.

Currently, they hold the position of Chief Commercial Officer (CCO) at Mahana.

Justin Zamirowski pursued their education at Illinois Wesleyan University from 1993 to 1997, where they obtained a Bachelor of Science degree in Biology, specifically in the field of study of Biology, General.